Cited by 555Long-Term Effects of COVID-19COVID-19 Clinical Research StudiesInfectious Encephalopathies and Encephalitis

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Immediate and long-term consequences of COVID-19 infections for the development of neurological disease

Open access

Heneka, Michael T., Golenbock, Douglas, Latz, Eicke, Morgan, Dave, Brown, Robert·2020·Alzheimer's Research & Therapy

DOI 10.1186/s13195-020-00640-3PMC PMC7271826

Open this paper in CoChat — free account Open PDF

Abstract

Increasing evidence suggests that infection with Sars-CoV-2 causes neurological deficits in a substantial proportion of affected patients. While these symptoms arise acutely during the course of infection, less is known about the possible long-term consequences for the brain. Severely affected COVID-19 cases experience high levels of proinflammatory cytokines and acute respiratory dysfunction and often require assisted ventilation. All these factors have been suggested to cause cognitive decline. Pathogenetically, this may result from direct negative effects of the immune reaction, acceleration or aggravation of pre-existing cognitive deficits, or de novo induction of a neurodegenerative disease. This article summarizes the current understanding of neurological symptoms of COVID-19 and hypothesizes that affected patients may be at higher risk of developing cognitive decline after overcoming the primary COVID-19 infection. A structured prospective evaluation should analyze the likelihood, time course, and severity of cognitive impairment following the COVID-19 pandemic.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1186/s13195-020-00640-3

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
COVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664
Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China
Mao, L., Jin, H., Wang, M., Hu, Y., Chen, S., He, Q., Chang, J., Hong, C., Zhou, Y., Wang, D., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.1127 · Cited by 7,166
Clinical and immunological features of severe and moderate coronavirus disease 2019
Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898
Self-citation
Neurologic features in severe SARS-CoV-2 infection
Helms, J., Kremer, S., Merdji, H., Clere-Jehl, R., Schenck, M., Kummerlen, C., Collange, O., Boulay, C., Fafi-Kremer, S., Ohana, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2008597 · Cited by 2,674
Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study
Lechien, J. R., Chiesa-Estomba, C. M., De Siati, D. R., Horoi, M., Le Bon, S. D., Rodriguez, A., Dequanter, D., Blecic, S., El Afia, F., Distinguin, L., et al. (2020) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-020-05965-1 · Cited by 2,668 · cited 1×
“Importantly, in about 11% of patients, anosmia occurred prior to any other clinical symptoms [3].”
Background
Long-term cognitive impairment and functional disability among survivors of severe sepsis.
Iwashyna, T. J., Ely, E. W., Smith, D. M., & Langa, K. M. (2010) · JAMA · doi:10.1001/jama.2010.1553 · Cited by 2,582
Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis
Rodriguez-Morales, A. J., Cardona-Ospina, J. A., Gutiérrez-Ocampo, E., Villamizar-Peña, R., Holguin-Rivera, Y., Escalera-Antezana, J. P., Alvarado-Arnez, L. E., Bonilla-Aldana, D. K., Franco-Paredes, C., Henao-Martinez, A. F., et al. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101623 · Cited by 2,542
Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young
Oxley, T. J., Mocco, J., Majidi, S., Kellner, C. P., Shoirah, H., Singh, I. P., Leacy, R. A. D., Shigematsu, T., Ladner, T. R., Yaeger, K., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2009787 · Cited by 2,114

Show all 27 references

Sorted by citations

Items 301–400 of 549

Aeromedical Implications of Long-Term COVID-19 Sequelae
Ko, S. Y., Nguyen, N. K., Lee, C. L., Lee, L. A., Nguyen, K. U. T., & Lee, E. C. (2021) · Aerospace Medicine and Human Performance · doi:10.3357/amhp.5928.2021 · Cited by 5
Potential role of Drug Repositioning Strategy (DRS) for management of tauopathy
Zaki, M. O., Elsherbiny, D. A., Salama, M., & Azab, S. S. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120267 · Cited by 6
“I Don’t Just Take Whatever They Hand to Me”: How Women Recently Released from Incarceration Access Internet Health Information
Schuster, B., Britton, H., Seo, H., Altschwager, D., Booton, E., Ault, M. M., Wickliffe, J., & Ramaswamy, M. (2022) · Women & Criminal Justice · doi:10.1080/08974454.2022.2040692 · Cited by 5
Understanding the Systemic Effects of COVID-19: Possible Clues to Potential Therapeutic Approaches
Aluko, O. M., Lawal, S. A., Reuben Celestine, S., Jeje, S. O., & Ijomone Omamuyovwi, M. (2022) · International Journal of Tropical Diseases · doi:10.23937/2643-461x/1710057 · Cited by 5
A mini-review: Application of the radiopharmaceutical [18F]DPA-714 in neuroinflammation research in post-SARS-CoV-2 patients
Boniek, D., & Malamut, C. (2025) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2025.123518 · Cited by 4
Fuzzy Cognitive Maps for Decision Support in Post-COVID Syndrome with Speech-Language Pathology-Related Problems
Tola, M., Georgopoulos, V. C., Geronikou, E., Plotas, P., & Stylios, C. D. (2024) · Applied Sciences · doi:10.3390/app15010013 · Cited by 4
International Balneology and Physical Medicine Conference «Challenges and Prospects of Public Health and Physical Medicine Development»
(2022) · Acta Balneologica · doi:10.36740/abal202201119 · Cited by 4
Post COVID – 19 neurological disorders; a single center experience; a case series
Ahmad, S. A., Mohammed, S. H., Abdullah, H. O., Salih, B. K., Hassan, M. N., Salih, A. M., Kakamad, F. H., Abdullah, H. O., Hassan, H. A., Othman, S., et al. (2022) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2022.103508 · Cited by 4
Mendelian Randomization Analyses Accounting for Causal Effect of COVID-19 on Brain Imaging-Derived Phenotypes
Lu, J., Huang, R., Peng, Y., Zhang, J., Liang, K., Wang, Y., Feng, Y., & Wang, Z. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230626 · Cited by 3
The duality of asthenia and cognitive impairments in cerebral diseases
Борисовна, Л. А., & Zakharov, V. V. (2023) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2023-401 · Cited by 4
The Multisystem effects of Long COVID Syndrome and Potential Benefits of Massage Therapy in Long COVID Care
Wheibe, E., Dalkin, B. H., Meltzer, H. C., Russ‐Sellers, R., & Grier, J. T. (2024) · International Journal of Therapeutic Massage & Bodywork Research Education & Practice · doi:10.3822/ijtmb.v17i1.767 · Cited by 4
Post-COVID-19 condition: a sex-based analysis of clinical and laboratory trends
Delfino, C., Poli, M. C., Vial, C., Vial, P., Martínez, G., Riviotta, A., Arbat, C., Mac-Guire, N., Hoppe, J., Carvajal, C., et al. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1376030 · Cited by 4
Neuropsychiatric disorders in the course to SARS-CoV-2 virus infection, including biological pathomechanisms, psychosocial factors and long COVID-19 associated with “brain fog”
Sadowski, J., Ostrowska, S. A., Klaudel, T., Zaborska, M., Chruszcz, M., Sztangreciak-Lehun, A., & Bułdak, R. J. (2025) · Journal of NeuroVirology · doi:10.1007/s13365-025-01242-1 · Cited by 4
Treatment experience of post-COVID cognitive impairment (clinical observation)
Zhitkova, Y. V., & Khasanova, D. R. (2022) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2022-16-11-102-107 · Cited by 4
The Infected Lungs and Brain Interface in COVID-19: The Impact on Cognitive Function
Joaquim, L. D. S., Giustina, A. D., Machado, R. S., Metzker, K. L. L., Bonfante, S., Danielski, L. G., Goldim, M. P. D. S., & Petronilho, F. C. (2022) · NeuroImmunoModulation · doi:10.1159/000526653 · Cited by 4
Exploring the relationship between novel Coronavirus pneumonia and Parkinson’s disease
Xi, X., & Han, L. (2022) · Medicine · doi:10.1097/md.0000000000031813 · Cited by 4
Postcovid cognitive impairment
Shishkova, V. N., & Галиевна, Д. Б. (2022) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202212212145 · Cited by 4
Multifactorial Causation of Alzheimer’s Disease Due to COVID-19
Monllor, P., Kumar, P., Lloret, M.-Á., Ftara, A., Leon, J.-L., Lopez, B., Cervera‐Ferri, A., & Lloret, A. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230396 · Cited by 4
The Relationship of ABO and Rh Blood Group Types With Severe COVID-19 Disease Mortality in ICU Patients: Insights From a Single-Center Experience in Southern Saudi Arabia
bshabshe, A. A. A. A., Alqahtani, M. S., Amer, K. A. N., Al-Jahash, N., Thwab, A. S., Alshahrani, F. S., Alshahrani, A. A., Asiri, O. A., Abughazalah, F. N. F., Khuzayyim, A. A. A., et al. (2023) · Cureus · doi:10.7759/cureus.50935 · Cited by 4
Approach to the main imaging findings resulting from Respiratory Syndrome caused by COVID-19
Ederli, R. B., Nascimento, M. A., Santos, E. C. M., Ederli, J. P. B., dos Santos, I. A., de Souza, R. R., do Nascimento, M. N., & Neves, F. A. B. (2020) · Research Society and Development · doi:10.33448/rsd-v9i8.6831 · Cited by 4
Differential Diagnosis and Hospital Emergency Management for Fastlane Treatment of Central Nervous System Infection Under the COVID-19 Epidemic in Changsha, China
Yang, H., Chi, Y., Chen, Z., Fan, Y., Wu, H., Hu, X., Wu, T. T., Xiao, B., & Zhang, M. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.555202 · Cited by 4
Profiling Cognitive Impairment in Mild COVID-19 Patients
Khanna, S. K., Khanna, N., Malav, M. K., Bayad, H. C., Sood, A., & Abraham, L. (2022) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_543_22 · Cited by 4
Ceylon cinnamon and its major compound Cinnamaldehyde can limit overshooting inflammatory signaling and angiogenesis in vitro : implications for COVID-19 treatmentPreprint
Lucas, K., Ackermann, M., Leifke, A. L., Li, W. W., Pöschl, U., & Fröhlich‐Nowoisky, J. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.16.448642 · Cited by 4
Complicações e sequelas neurológicas e psiquiátricas da COVID-19: uma revisão sistemática
Cerdeira, C. D. (2022) · VITTALLE - Revista de Ciências da Saúde · doi:10.14295/vittalle.v34i3.14460 · Cited by 6
Prion propensity of Betacoronaviruses including SARS-CoV-2
Haddad, H. I., & Al-Zyoud, W. A. (2025) · Heliyon · doi:10.1016/j.heliyon.2025.e42199 · Cited by 3
Post-COVID Condition and Neuroinflammation: Possible Management with Antioxidants
Cárdenas‐Rodríguez, N., Ignacio‐Mejía, I., Mejía-Barradas, C. M., Ortega-Cuéllar, D., Muñoz-González, F., Vargas-Hernández, M. A., Méndez, E. M. A., Ibáñez-Cervantes, G., Medina‐Santillán, R., Hernández-Ortiz, A., et al. (2025) · Antioxidants · doi:10.3390/antiox14070840 · Cited by 5
BIOBASED NANOEMULSION FOR BLOCKING COVID-19 FROM ACCELERATING ALZHEIMER'S DISEASE
D'Arrigo, J. S. (2021) · Juvenis scientia · doi:10.32415/jscientia_2021_7_4_5-11 · Cited by 3
Higher Inflammatory Markers are correlated with Worse Cognitive Function in Coronavirus Disease-2019 Patients
Fitri, F. I., Darman, W. R., & Ritarwan, K. (2022) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2022.9472 · Cited by 3
An Update on Complications Associated with SARS-CoV-2 Infection and COVID-19 Vaccination
Chowdhury, P., Bhattacharya, S., Gogoi, B., Veeranna, R. P., & Kumar, S. (2022) · Vaccines · doi:10.3390/vaccines10101639 · Cited by 3
Bioinformatics and systems biology approaches to identify the effects of COVID-19 on neurodegenerative diseases: A review
Bu, F., Guan, R., Wang, W., Liu, Z., Yin, S., Zhao, Y., & Chai, J. (2022) · Medicine · doi:10.1097/md.0000000000032100 · Cited by 4
Post-COVID-19 and Mental Health
Safiye, T., Milidrag, A., Čekić, S., Dubljanin, D., Kovačević, A., Zlatanović, M., Markišić, M., Despotović, M., & Gutić, M. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.110409 · Cited by 3
Delayed mental, neurological and somatic disorders associated with COVID-19
Belyakov, N. А., Рассохин, В. В., Totolyan, N. A., Boeva, E. V., Бобрешова, А. С., Khalezova, N. B., Kushnir, Y. B., & Norka, A. O. (2024) · HIV Infection and Immunosuppressive Disorders · doi:10.22328/2077-9828-2023-15-4-53-62 · Cited by 3
Machine learning predictive modeling of the persistence of post-Covid19 disorders: Loss of smell and taste as case studies
Alhassoon, K., Alhsaon, M. A., Alsunaydih, F. N., Alsaleem, F., Salim, O., Aly, S., & Shaban, M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35246 · Cited by 3
Self‐reported immune status and COVID‐19 associated subjective cognitive functioning in post‐COVID‐19 syndrome: Examination of an Irish cohort
Holland, J. F., Brown, S. A., O'Flanagan, S., Savinelli, S., McCann, K., Gaynor, K., Mallon, P. W. G., Feeney, E. R., Kenny, G., Boyd, C., et al. (2024) · Brain and Behavior · doi:10.1002/brb3.70027 · Cited by 3
Serotonergic psychedelics as potential therapeutics for post-COVID-19 syndrome (or Long COVID): A comprehensive review
Low, Z. X. B., Yong, S. J., AlRasheed, H. A., Al‐Subaie, M. F., Kaabi, N. A., Alfaresi, M. S., Albayat, H., Alotaibi, J., bshabshe, A. A. A. A., Alwashmi, A. S. S., et al. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111279 · Cited by 4
COVID-19: Achieving Maximum Medical Improvement and Assessing Permanent Impairment
Talmage, J. B., Hyman, M. H., Brigham, C. R., Gulick, S. H., & Burton, L. (2021) · AMA guides newsletter · doi:10.1001/amaguidesnewsletters.2021.marapr01 · Cited by 3
Actovegin use in patients with cognitive impairment after coronavirus infection (COVID-19)
Куташов, В. А. (2021) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2021-2-65-72 · Cited by 3
Impact of coronavirus infection on cognitive functions in elderly patients
Potupchik, T. V., Evert, L. S., & Kostyuchenko, Y. R. (2021) · Vrach · doi:10.29296/25877305-2021-06-08 · Cited by 20
The association of ABO and Rhesus blood type with the risks of developing SARS-CoV-2 infection: A meta-analysis
K-M., S. (2022) · Tropical biomedicine · doi:10.47665/tb.39.1.015 · Cited by 3
Ataxia Myoclonus Syndrome in Mild Acute COVID-19 Infection
Rodriguez-Quiroga, S. A., Aldecoa, M., Morera, N., Gatti, C., Gil, C., Garretto, N., & Fasano, A. A. (2022) · The Cerebellum · doi:10.1007/s12311-022-01460-x · Cited by 3
Neurological manifestations in patients with new coronavirus infection COVID-19
Sсherbak, S. G., Голота, А. С., Kamilova, Т. A., Vologzhanin, D. A., & Макаренко, С. В. (2022) · Physical and rehabilitation medicine medical rehabilitation · doi:10.36425/rehab109952 · Cited by 3
Neurological Complications of SARS-CoV-2 Infection and COVID-19 Vaccines: From Molecular Mechanisms to Clinical Manifestations
Yepes, M. (2022) · Current Drug Targets · doi:10.2174/1389450123666220919123029 · Cited by 4
Patients’ Post-/Long-COVID Symptoms, Vaccination and Functional Status—Findings from a State-Wide Online Screening Study
Lippke, S., Rinn, R., Derksen, C., & Dahmen, A. (2023) · Vaccines · doi:10.3390/vaccines11030691 · Cited by 3
Acceptance and hesitancy of COVID-19 vaccine among university community members of Otukpo, Nigeria: a cross-sectional study
Zakari, S., Ogbu, C. O., Zakari, H., Eze, S. C., Ijimbili, S. B., Idoko, J. E., Emmanuel, A. O., Amuji, D. N., Agwara, B. C., Adokiye, E. S., et al. (2023) · Discover Global Society · doi:10.1007/s44282-023-00013-9 · Cited by 3
1
Дзяк, Л. А., Tsurkalenko, O. S., Chekha, K., & Suk, V. (2021) · INTERNATIONAL NEUROLOGICAL JOURNAL · doi:10.22141/2224-0713.17.2.2021.229887 · Cited by 3
Effect of pandemic-induced PTSD in pregnant women on infant physical growth: a prospective cohort study
Ye, F., Chen, J., Gao, X., Lin, H. D., Chen, Y., Liu, J., Sun, Q., & Zhang, Q. (2024) · BMC Pediatrics · doi:10.1186/s12887-024-05244-6 · Cited by 2
Cognitive impairment in asthenic disorders
Chutko, L. S., Surushkina, S. Y., Yakovenko, E. A., Scheglova, L. V., & Мирзаева, Л. М. (2025) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202512503127 · Cited by 2
Trends in cognitive impairment among older adults in China from 2002 to 2022: Evaluating the impact of the COVID-19 pandemic
Feng, L., Ye, K. X., Feng, Q., Mo, Y., Zuqi, C., Li, C., Yu, J., Li, B., Maier, A. B., Zeng, Y., et al. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100370 · Cited by 3
Hormonal contraceptives modulate resilience to psychiatric and neurodegenerative disease
Schuh, K. M., Conrad, L. M., & Tronson, N. C. (2025) · Hormones and Behavior · doi:10.1016/j.yhbeh.2025.105823 · Cited by 2
Exploring the relationship between subjective cognitive concerns, psychiatric symptom reporting, and objective neurocognitive test performance in a post-SARS-CoV-2 clinical sample
Boulais, B. M., Finley, J. A., Cichocki, A. C., Gonzalez, C., Dykins, M. M., Sedgwick, T. A., Pliskin, N. H., Jennette, K. J., Tsai, P., Maniar, N., et al. (2025) · Cognitive Neuropsychiatry · doi:10.1080/13546805.2025.2566649 · Cited by 2
Nitric Oxide at the Nexus of ACE2 Biology and COVID-19: Implications for Cardiovascular and Neurodegenerative Comorbidities
Pecháňová, O., & Paulis, L. (2025) · Physiological Research · doi:10.33549/physiolres.935729 · Cited by 2
Reflexões éticas e legais sobre a prática odontológica em tempos de pandemia de COVID-19
Pinheiro, F. D. A., Coltri, M. V., Pereira, J. G. D., & da Silva, R. H. A. (2021) · Saúde Ética & Justiça · doi:10.11606/issn.2317-2770.v26i1p27-35 · Cited by 2
The Politics of Life and Death in the Time of COVID-19
Travaglia, J., & Robertson, H. A. (2021) · Organizational behaviour in health care · doi:10.1007/978-3-030-82696-3_13 · Cited by 2
Effects of Varying Glucose Concentrations on ACE2′s Hypothalamic Expression and Its Potential Relation to COVID-19-Associated Neurological Dysfunction
Srivastava, A., & Mussa, B. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179645 · Cited by 2
Unmasking the long-term effects: unravelling neuropsychiatric and neurological consequences of COVID-19
Tariq, M., Mahak, F., Kumar, R., Kumar, A., Kumar, A., Khan, J. A., Muhammad, M. A., Memon, U., Maqsood, K. M., Tanveer, F. S., et al. (2024) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000001624 · Cited by 4
Post-Covid Syndrome: from Biology to Neuropsychology
Karchevskaya, A. Е., Vologdina, Y. O., Зайцев, О. С., & Максакова, О. А. (2024) · Moscow University Psychology Bulletin · doi:10.11621/lpj-24-02 · Cited by 2
Population ageing and public finance burden of dementia: Micro-simulations evaluating risk factors, treatments and comorbidities in Luxembourg
Alperin, M. N. P., Perquin, M., & Giordana, G. A. (2024) · The Journal of the Economics of Ageing · doi:10.1016/j.jeoa.2024.100517 · Cited by 2
SARS-CoV-2 Spike Protein Exacerbates Thromboembolic Cerebrovascular Complications in Humanized ACE2 Mouse Model
Heath, S. P., Hermanns, V. C., Coucha, M. M., & Abdelsaid, M. A. (2024) · Translational Stroke Research · doi:10.1007/s12975-024-01301-5 · Cited by 2
Serum antineuronal antibodies in patients with post-COVID-19 condition − association to intensive care
Posharina, T., Varonen, M., Jarva, H., Kanerva, M. J., Liira, H., & Laakso, S. M. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.05.026 · Cited by 2
A importância da reabilitação pulmonar em pacientes com COVID-19
Bosi, P. L., Januzzi, L. F. D. F., de Paula, P. B., de Oliveira, C. C., Scianni, C. A., da Costa, T. A. B. N., Teixeira, C. T. M. D. F., Gomes, R. B. D. O., Clovis, A. S., GONÇALVES, G. A. D. S., et al. (2021) · Fisioterapia Brasil · doi:10.33233/fb.v22i2.4288 · Cited by 4
The Effective Cognitive Assessment and Training Methods for COVID-19 Patients With Cognitive Impairment
Dong, W., Xu, J. B., Wu, Z., Liu, Y., Zhou, Y., Li, J., Wang, S., Dong, X., Saripan, M. I., & Song, H. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.827273 · Cited by 2
Brain Biomarkers in Patients with COVID-19 and Neurological Manifestations: A Narrative Review
Tyagi, M., Kapoor, I., Mahajan, C., Gupta, N., & Prabhakar, H. (2022) · Journal of Neuroanaesthesiology and Critical Care · doi:10.1055/s-0042-1744395 · Cited by 3
Post-COVID 19 neurological syndrome: Are we facing a neuropsychiatric phenotype?
Rubiano-Buitrago, J. D., Rahiran-Ramírez, A. F., Peña-Vargas, D. M., Paez-Rincon, L. A., & Lozada-Martínez, I. D. (2022) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2022.01.010 · Cited by 2
Manifestaciones cognitivas y neuropsiquiátricas de COVID-19 en el Adulto Mayor con y sin demencia: Revisión de la literatura.
Bombón-Albán, P. E., & Salazar, J. V. S. (2022) · Revista de Neuro-Psiquiatría · doi:10.20453/rnp.v85i2.4229 · Cited by 2
Post-Covid-19 Syndrome: symptoms and stratified follow-up. A systematic review and meta-analysis
Matteo, R. D., Bolgeo, T., Gatti, D., Gardalini, M., Cassinari, A., & Maconi, A. (2022) · Working Paper of Public Health · doi:10.4081/wpph.2022.9540 · Cited by 2
Psychological experiences of patients recovering from severe COVID-19 in rehabilitation: A qualitative study
Gershfeld-Litvin, A., & Ressler, I. (2023) · Journal of Health Psychology · doi:10.1177/13591053231174940 · Cited by 2
Social Biases During Covid 19
Kulesza, W. M., & Doliński, D. (2023) · SpringerBriefs in psychology · doi:10.1007/978-3-031-34706-1 · Cited by 2
Poor Sleep Quality and Working From Home Influence the Prevalence of Leisure Time Physical Inactivity During the COVID-19 Pandemic
de Moura, S. S., de Menezes-Júnior, L. A. A., Carraro, J. C. C., Machado-Coelho, G. L. L., & Meireles, A. L. (2023) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000002930 · Cited by 2
Neurological Involvements in COVID-19: A hospital-based study.
Montazerlotfelahi, H., Norouzi, M., Askarimoghaddam, F., Hashemnejad, M. A., Sarabi, N. B., Qorbani, M., Dehghani, M., Ashrafi, M. R., Mostafavi, K., Ketabforoush, A. H. M. E., et al. (2023) · Iranian journal of child neurology. · doi:10.22037/ijcn.v17i2.36829 · Cited by 2
A Multi-Dimensional Psychiatric Perspective on the Impact of the COVID-19 Pandemic
Poyraz, C. A., Demirel, Ö. F., Poyraz, B. Ç., & Dursun, S. M. (2021) · Psychiatry and Clinical Psychopharmacology · doi:10.5152/pcp.2021.21222 · Cited by 2
Kesehatan Mental Mahasiswa Fakultas Kedokteran Di Masa Pandemi COVID-19
Taufiqy, A. (2021) · ARTERI Jurnal Ilmu Kesehatan · doi:10.37148/arteri.v2i4.184 · Cited by 2
Long Term Complications Associated with Covid-19 : A Review
Joshi, A. (2020) · International Journal of Innovative Science and Research Technology (IJISRT) · doi:10.38124/ijisrt20sep144 · Cited by 2
Long Covid and persistent headache
Valênça, M. M., de Andrade, J. R., & Peres, M. F. P. (2020) · Headache Medicine/Revista Headache Medicine · doi:10.48208/headachemed.2020.23 · Cited by 2
Brain and Central Nervous System Infections: Viruses
de Almeida, S. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818731-9.00123-3 · Cited by 4
How Did Poor Sleep Quality and Working from Home Influence the Prevalence of Leisure‑time Physical Inactivity During the Covid-19 Pandemic? COVID‑InconfidentesPreprint
de Moura, S. S., de Menezes-Júnior, L. A. A., Carraro, J. C. C., Machado-Coelho, G. L. L., & Meireles, A. L. (2022) · Preprints.org · doi:10.20944/preprints202212.0102.v1 · Cited by 2
Role of SARS-CoV-2 Virus in Brain Cells: A Brief ReviewPreprint
Azargoonjahromi, A. (2022) · doi:10.22541/au.167156299.92004774/v1 · Cited by 2
COVID-19 and the nervous system: pathogenesis, mechanisms, and outcomes
Takenova, L., & Klyuyev, D. A. (2024) · Medicine and ecology · doi:10.59598/me-2305-6045-2024-112-3-43-50 · Cited by 1
ALTERAÇÕES COGNITIVAS E FUNCIONAIS ENCONTRADAS NA SÍNDROME PÓS-COVID-19 EM PESSOAS IDOSAS: REVISÃO INTEGRATIVA
Rodrigues, I. F. A., Silva, K. H. C. V. E., Stephanus, A. D., & de Carvalho, L. S. F. (2024) · Cogitare Enfermagem · doi:10.1590/ce.v29i0.93477 · Cited by 1
Post-COVID-19 Neuropathology and Perspectives of Protective Roles of Estrogens
Ureshino, R. P., Stilhano, R. S., Prado, C. M., & Newson, L. R. (2025) · COVID · doi:10.3390/covid5010009 · Cited by 1
Cognitive functioning in young adults after mild COVID-19: A case-control study from Iran
Akbarzadeh, F., Farıdhosseını, F., Eslamzadeh, M., Ghalandarzadeh, M., Khaniki, S. H., & Ebrahimi, A. (2025) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2025.06.003 · Cited by 1
Immune-mediated mechanisms of cognitive memory dysfunction: From autoimmune diseases to therapeutic neuromodulation
Shtoots, L., Halpert, G., Partouche, R., Levy, D. A., Amital, H., & Shoenfeld, Y. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149980 · Cited by 1
Leveraging multimodal large language models to extract mechanistic insights from biomedical visuals: A case study on COVID-19 and neurodegenerative diseases
Popova, E., Jacobs, M. D., Hofmann‐Apitius, M., & Babaiha, N. S. (2025) · Machine Learning with Applications · doi:10.1016/j.mlwa.2025.100816 · Cited by 1
Integrative Multi‐Omics Analysis Reveals Age‐Associated Molecular Mechanisms in SARS‐CoV‐2 Infection
Tang, X., Xiao, Y., Zhong, J., Ding, T., Wang, Q., Shi, C., Zhang, Z., Yang, Y., Wu, Y., Liu, J., et al. (2025) · Journal of Medical Virology · doi:10.1002/jmv.70730 · Cited by 1
mRNA-based SARS-CoV-2 vaccines: intracellular processing and aggregation of the encoded spike protein as a mechanistic contributor to cardiac cellular stress
Schreckenberg, R., Woitasky, N., Itani, N., Czech, L., Windhorst, A., Juchem, M., Bär, C., Thum, T., Ferdinandy, P., & Schulz, R. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1635478 · Cited by 1
Admission Serum Inflammatory and Injury Biomarkers Are Associated with In-Hospital Mortality in Neurological Inpatients with Confirmed SARS-CoV-2 Infection: The Brain-COVID Cohort Study
Zielińska-Turek, J., Czyżewski, W., Turek, G., Łysoń, T., Gajewski, J., Gierszon, P., Turek, M., Kuś-Budzyńska, K., & Dorobek, M. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48020228 · Cited by 1
Unraveling the Link Between COVID-19 and Memory Deficits: The Role of Brain Microglia Activation
Aktaruzzaman, M., Abid, M. A., Rakib, M. A., Islam, M. S., Dona, H. A., Tabassum, A., Hossain, N., Sezin, S. N., Metu, C. L. N., & Raihan, M. O. (2026) · Neuroglia · doi:10.3390/neuroglia7010010 · Cited by 1
Psychiatric and Neurological Involvement in COVID-19 Hospitalized Patients Through the Global Pandemic in Central Romania
Lupu, C. D., Cotuţiu, V.-D., & Bîrluțiu, V. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15083030 · Cited by 1
Excitotoxicity and Neurological Post-COVID-19 Syndrome: Exploring Possible Connections of Pathophysiological Mechanisms
Ureshino, R. P., de Sousa, L. A., Oliveira, R. B., Saullo, G. A., Zonaro, P. H., Newson, L. R., Prado, C. M., & Stilhano, R. S. (2026) · COVID · doi:10.3390/covid6050085 · Cited by 1
Persistent Redox Imbalance in Post-COVID-19 Syndrome: Lipid Peroxidation, Antioxidant Enzyme Depletion, and Reduced Nitric Oxide Availability in an Amazonian Population
Silva, R. C., Quaresma, J. A. S., Mineshita, B. K. H., Costa, M. E. A., Reis, V. M. C., da Silva, C. I. M., Pinheiro, R. F., Barbosa, L. G. V., Miranda, K. J. S., Chaves, E. C. R., et al. (2026) · Antioxidants · doi:10.3390/antiox15081013 · Cited by 1
Dementia and COVID-19 in Chile, New Zealand and Germany: A Research Agenda for Cross-Country Learning for Resilience in Health Care Systems
Uribe, F. L., Arteaga, Ó., Bruchhausen, W., Cheung, G., Cullum, S. J., Fuentes‐García, A., Miranda‐Castillo, C., Kerse, N. M., Kirk, R., Muru‐Lanning, M., et al. (2021) · Sustainability · doi:10.3390/su131810247 · Cited by 1
Health Inequity and COVID-19
Blume, A. W. (2022) · International and cultural psychology/International and cultural psychology series · doi:10.1007/978-3-030-92825-4_6 · Cited by 1
Complications after SARS-CoV2 virus infection in the respiratory, cardiovascular, nervous systems and in the kidneys.
Brzyska, A., Bogucka, J., Bojarska, M. K., Domańska, N. A., & Piecewicz‐Szczęsna, H. (2022) · Journal of Education Health and Sport · doi:10.12775/jehs.2022.12.04.006 · Cited by 1
Perspectives on the Use of Small Noncoding RNAs as a Therapy for Severe Virus-Induced Disease Manifestations and Late Complications
Klimenko, O. V. (2022) · BioNanoScience · doi:10.1007/s12668-022-00977-z · Cited by 1
An impact of the novel coronavirus infection (COVID-19) on human reproductive function
Garibidi, E. V., Шатунова, Е. П., Федорина, Т. А., & Garibidi, D. E. (2022) · Obstetrics Gynecology and Reproduction · doi:10.17749/2313-7347/ob.gyn.rep.2022.277 · Cited by 1
Cerebral Aspergillosis in an Immunocompetent Patient after COVID-19 Infection
Almeida, L. C. A., Braga, H. M., & Costa, B. S. (2022) · Arquivos Brasileiros de Neurocirurgia Brazilian Neurosurgery · doi:10.1055/s-0042-1748845 · Cited by 1
Vitamin D Deficiency - New Insights
Fedotova, J. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100904 · Cited by 1
New Imaging Modality of COVID-19 Pneumonia Developed on the Basis of Alzheimer’s Disease Research
Koźmiński, P., Niedziałek, D., Wieczorek, G., Halik, P. K., Czarnecka, K., Rogut, A., Cheda, Ł., Rogulski, Z., Szymański, P., & Gniazdowska, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158405 · Cited by 1
Alzheimer's disease and COVID-19
Koberskaya, N. N., & Roshchin, P. (2022) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2022-6-89-97 · Cited by 1
On the Role of Geriatric Services in the Diagnosis and Monitoring of Outcomes of Post-Covid Syndrome (Review)
Lapteva, E. S., Ariev, A. L., Арьева, Г. Т., Tsutsunava, M. R., & Diachkova-Gerceva, D. C. (2022) · Advances in Gerontology · doi:10.1134/s2079057022040105 · Cited by 1
The Association between ABO System and Rh Factor with COVID-19 in Basrah Province, Iraq
Al-Amiri, R. M., Fadhil, A. G., & Al-Khaqani, F. (2022) · Journal of Hunan University Natural Sciences · doi:10.55463/issn.1674-2974.49.12.19 · Cited by 1

Authors: Heneka, M. T., Golenbock, D., Latz, E., Morgan, D., & Brown, R.
Affiliations: University of Bonn (DE)
German Center for Neurodegenerative Diseases (DE)
University of Massachusetts Chan Medical School (US)
Corresponding author: Heneka, Michael T.
ORCID: Heneka, Michael T.
Golenbock, Douglas
Latz, Eicke
Brown, Robert
Venue: Alzheimer's Research & Therapy
Publisher: Springer Science and Business Media LLC
Published: 2020-06-04
Volume: 12
Issue: 1
Pages: 69-69
ISSN: 1758-9193 (ISSN-L)
DOI: 10.1186/s13195-020-00640-3
PMC: PMC7271826
OpenAlex: W3032981909
Cited by: 555
References: 27
Citations by year: 2026: 18 · 2025: 36 · 2024: 74 · 2023: 72 · 2022: 165 · 2021: 137 · 2020: 52
FWCI: 46.12
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0 (tdm)
creativecommons.org/licenses/by/4.0 (vor)
Locations: Alzheimer s Research & Therapy (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion, cc-by)
Open Repository and Bibliography (University of Luxembourg) (submittedVersion, other-oa)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
DZNE Pub (submittedVersion, cc-by)
Funders: National Institutes of Health
National Institute on Aging (R01AG059752)
Topics: Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Health Sciences › Medicine › Infectious Diseases › Infectious Encephalopathies and Encephalitis
Keywords: COVID-19 pandemic, SARS-CoV-2, neurological complications, cognitive decline, long-term effects, neuroinflammation, inflammatory cytokines, neurodegenerative diseases, post-COVID cognitive impairment, mechanical ventilation
MeSH terms: Betacoronavirus, COVID-19, SARS-CoV-2, Animals, Brain, Humans, Pneumonia, Viral, Time Factors, Coronavirus Infections, Neurodegenerative Diseases, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Immediate and long-term consequences of COVID-19 infections for the development of neurological disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks